High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia. [electronic resource]
- Cancer Mar 1987
- 1083-6 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0008-543X
10.1002/1097-0142(19870315)59:6<1083::aid-cncr2820590606>3.0.co;2-p doi